RFK Jr. Confronted With Surgeon General Pick's Lack of Cred
Trump announced Wednesday that he would nominate Dr. Casey Means as America's top doctor, replacing Fox News contributor Dr. Janette Nesheiwat, whose nomination got pulled due to questions over her medical credentials. But the same questions over medical credentials that plagued Nesheiwat have come for Means, too.
Though she received a Stanford education, Means dropped out of her residency at age 30 and has an inactive medical license. When quizzed directly by Fox News' Bret Baier on the fact the she doesn't currently hold a medical license, Kennedy listed Means' apparent achievements that to his mind are key to undertaking the role, claiming she was at the 'top of her medical class' and 'won every award that she could win' during her residency.
'Casey Means, we felt, was the best person to really bring the vision of MAHA to the American public,' Kennedy told Special Report on Thursday. 'She has this unique capacity to articulate it. She's written a book that really mobilized, galvanized the movement,' Kennedy added, referencing Good Energy: The Surprising Connection Between Metabolism and Limitless Health, the book she wrote with her influencer brother, Calley.
Means, also a wellness influencer, grew her following by advocating for alternative approaches combining science and spirituality over traditional medicine. She and her brother were the brains behind Kennedy's Make America Healthy Again movement.
Kennedy said Means walked away from traditional medicine because she felt that she was just 'billing new procedures' instead of actually curing patients.
'We actually have to figure out new approaches to medicine, and that's the kind of leadership that she's going to bring to our country,' he said.
MAGAworld, led by firebrand Laura Loomer, branded Means a 'Marxist tree-hugger.' Kennedy's own former running mate, Nicole Shanahan, said Means' nomination was 'strange' and 'doesn't make any sense.'
Trump, for his part, pointed the finger at Kennedy when faced with questions over Means' credentials.
'Bobby thought she was fantastic,' he told reporters. 'Bobby really thought she was great. I don't know her. I listened to the recommendation of Bobby. I met her yesterday, and once before, she's a very outstanding person, a great academic, actually. So I think she'll be great.'
In the wide-ranging Fox News interview, Kennedy was flanked by Food and Drug Administration chief Marty Makary, Medicare and Medicaid administrator Mehmet Oz, and National Institutes of Health director Jay Bhattacharya.
The health officials rehashed dubious claims that the COVID-19 pandemic was 'lab-generated,' food products are 'loaded with chemicals that's gonna poison your children,' and the U.S. is the 'sickest country in the world.'
'You got sitting here four people who were all canceled during COVID,' Kennedy said. 'The entire leadership of this agency is renegades who are, you know, who are juggernauts against convention, and are trying to look for truth, no matter what the cost.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
13 minutes ago
- The Hill
6 months in, Trump's unorthodox foreign policy is rewriting the rules
President Trump's return to office has marked a fundamental departure from conventional foreign policy approaches that have dominated Washington for decades. His first six months demonstrate how unorthodox methods — transactional negotiations, direct pressure and strategic leverage — can achieve breakthroughs that traditional diplomatic playbooks consistently failed to deliver. The results challenge long-held assumptions about international relations. Where successive administrations have relied on multilateral consensus-building and careful diplomatic protocol, Trump has moved decisively to address longstanding challenges through direct engagement and clear incentives. The outcomes speak for themselves: concrete achievements that decades of conventional wisdom could not produce. The June NATO summit in Brussels exemplifies this transformation. Trump secured an unprecedented agreement from member nations to increase defense spending to 3.5 percent of GDP by 2035, with Poland, Estonia, and Lithuania committing to reach 5 percent within the decade. This represents the largest collective defense spending increase since the alliance's founding. For decades, American presidents from both parties have struggled to convince NATO allies to shoulder more of the defense burden. George W. Bush, Barack Obama and others made passionate appeals with minimal results. Trump's direct pressure on individual leaders — including frank conversations about the consequences of continued free-riding — achieved what 20 years of diplomatic consensus-building could not. The breakthrough reveals how Trump's willingness to challenge diplomatic norms can produce substantive results. When allies understand that America's patience with free-riding has limits, they respond accordingly. Perhaps nowhere is Trump's departure from conventional wisdom more evident than in Iran policy. His coordination with Israel on strikes against Iranian nuclear facilities in July set back Tehran's nuclear program by up to two years according to Pentagon officials cited by Reuters — a more concrete achievement than decades of sanctions and diplomatic engagement that was slow-walking Tehran to having a nuclear bomb. This wasn't reckless escalation — it was calculated deterrence after years of failed accommodation strategies that spanned multiple administrations. Iran's subsequent diplomatic overtures to European partners suggest the strikes achieved their intended effect. Where traditional approaches allowed Iran's regional influence to grow unchecked, Trump's decisive action has forced Tehran to recalculate its strategic position. The success challenges the foreign policy establishment's preference for extended diplomatic processes over direct action. Sometimes, as Trump demonstrates, credible threats require credible follow-through. Immigration policy demonstrates another area where Trump's approach has succeeded. New agreements with Mexico and Central American nations include enhanced enforcement provisions and expanded return protocols, contributing to a more than 90 percent reduction in detected border crossings in May compared to the previous year, according to Department of Homeland Security data. The key difference lies in leverage. Trump used trade access and visa negotiations to secure these commitments, demonstrating that America's economic power can be an effective diplomatic tool. Mexico agreed to deploy additional forces along its southern border in exchange for streamlined trade procedures — a classic win-win arrangement that Biden's team never successfully negotiated. This success highlights a broader truth about international relations: Countries respond to clear incentives and consequences. When America articulates its interests clearly and backs them with appropriate leverage, even reluctant partners find ways to cooperate. Trump's approach to Africa represents a fundamental departure from the aid-focused diplomacy that characterized previous administrations. Rather than continental tours filled with promises of development assistance, Trump has hosted five African leaders at the White House in recent months, emphasizing trade and investment opportunities. This shift addresses a critical gap in American foreign policy. While recent presidents maintained traditional approaches that often created dependency relationships, Trump is building partnerships based on mutual economic interest. Early agreements with Liberia and Senegal focus on critical mineral extraction and energy partnerships — arrangements that benefit both American businesses and African development. The message is clear: America seeks partners, not dependents. By reframing relationships around mutual economic interest rather than charity, Trump is building more sustainable and dignified partnerships. Perhaps most surprisingly, Trump's tough approach has yielded diplomatic breakthroughs that eluded his predecessor. In late June, he hosted talks between Rwanda and the Democratic Republic of Congo that produced a cease-fire agreement including troop withdrawals and commitments to joint economic development. The success came from Trump's willingness to use America's full diplomatic and economic weight — not to lecture, but to incentivize. This contrasts sharply with Biden's reactive approach to international crises, which often left the U.S. struggling to respond effectively to fast-moving global events. As we assess these first six months, the question isn't whether Trump's methods conform to diplomatic norms — it's whether they work. The evidence suggests they do. In a world where traditional institutions struggle to address complex challenges, Trump's transactional approach offers a compelling alternative. His first six months suggest that sometimes bold action succeeds where diplomatic convention fails. Kurt Davis Jr. is a Millennium Fellow at the Atlantic Council and a member of the Council on Foreign Relations. He is also an advisor to private, public, and state-owned companies and their boards as well as creditors across the globe on a range of transactions.
Time Magazine
14 minutes ago
- Time Magazine
House Panel Defies Trump in Vote to Subpoena Epstein Files
The House Oversight Committee is preparing to subpoena the Justice Department for its files related to the sex trafficking investigation into the disgraced financier Jeffrey Epstein, after three Republicans broke with their party to join Democrats to vote on the matter. In an 8-to-2 vote late Wednesday, the panel's Federal Law Enforcement Subcommittee approved the motion to compel the release of records, a rare moment of bipartisan agreement regarding an investigation that has long been shrouded in mystery. The vote came amid a tense week in which Speaker Mike Johnson abruptly announced he was sending lawmakers home a day early for its five-week recess—an apparent move to avoid precisely this kind of politically fraught vote involving Epstein. But Oversight Committee Democrats, led by Rep. Summer Lee of Pennsylvania, put together a last-minute effort to force Republicans to go on the record. Joining Democrats in the vote were GOP Reps. Nancy Mace of South Carolina, Scott Perry of Pennsylvania, and Brian Jack of Georgia. Subcommittee Chairman Clay Higgins of Louisiana and Rep. Andy Biggs of Arizona were the only no votes. The subpoena directs the Justice Department to hand over investigative materials, with redactions to protect victims' identities and exclude any imagery depicting child sexual abuse. The documents would be reviewed by the committee internally, not released publicly. 'The American people deserve transparency and accountability,' Lee wrote on X, 'and [Epstein's] victims deserve justice. The wealthy and powerful are not above the law.' The committee also issued subpoenas for a deposition from Ghislaine Maxwell—Epstein's longtime confidante who is serving a 20-year sentence for sex trafficking—and requested testimony from a sweeping list of political and law enforcement figures. Among them: former President Bill Clinton and Donald Trump's former attorneys general, as well as former FBI directors James Comey and Robert Mueller. While Trump has long been at the center of Epstein-related speculation, he has recently tried to distance himself from the issue, dismissing the continued focus on Epstein as 'bulls---.' On the campaign trail, Trump and his surrogates previously claimed they would be willing to investigate Epstein's 'client list,' but later resisted formal efforts to obtain more information. The issue has sharply divided Republicans. Some of Trump's most vocal allies accuse his Administration of falling short of its promises, while others fear the files include damaging disclosures involving Trump. The Wall Street Journal reported Wednesday that Attorney General Pam Bondi told Trump in May that his name appeared multiple times in Department of Justice documents about Epstein, citing senior Administration officials. House Democratic leaders have seized on the internal rift. 'Speaker Johnson is definitely facilitating a cover up of epic proportions by shutting down Congress early to avoid voting on the Epstein files,' Rep. Ted Lieu of California, vice chair of the House Democratic Caucus, tells TIME. 'And we know Trump is all over the released Epstein files, and now we know he's all over the unreleased Epstein files, so Speaker Johnson should listen to the will of the American people instead of covering up for Donald Trump.' Even some Republicans who supported the subpoena effort tried to narrow its scope. Rep. Mace successfully added language requiring the Justice Department to include any communications with former President Joe Biden about Epstein and to shield the identities of victims. Democrats, however, blocked a GOP attempt to limit the subpoena to only information deemed 'credible.' The Justice Department has said it continues to review files from the Epstein investigation but maintains that no 'client list' has been found and that there is no credible evidence Epstein blackmailed powerful individuals.
WIRED
14 minutes ago
- WIRED
An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US
Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for access to an AI-driven but entirely unproven treatment that includes injecting a highly concentrated dose of chlorine dioxide, a toxic bleach solution, directly into cancerous tumors. One patient tells WIRED her tumor has grown faster since the procedure and that she suspects it may have caused her cancer to spread—a claim Liu disputes—while experts allege his marketing of the treatment has likely put him on the wrong side of US regulations. Nonetheless, while Liu currently only offers the treatment informally in China and at a German clinic, he is now working with a Texas-based former pharmaceutical executive to bring his treatment to America. They believe that the appointment of Robert F. Kennedy Jr. as health secretary will help 'open doors' to get the untested treatment—in which at least one clinic in California appears to have interest—approved in the US. Kennedy's Make America Healthy Again (MAHA) movement is embracing alternative medicines and the idea of giving patients the freedom to try unproven treatments. While the health secretary did not respond to a request for comment about Liu's treatment, he did mention chlorine dioxide when questioned about President Donald Trump's Operation Warp Speed during his Senate confirmation hearing in February, and the Food and Drug Administration recently removed a warning about substance from its website. The agency says the removal was part of a routine process of archiving old pages on its site, but it has had the effect of emboldening the bleacher community. 'Without the FDA's heavy-handed warnings, it's likely my therapy would have been accepted for trials years earlier, with institutional partnerships and investor support,' Liu tells WIRED. He says he wrote to Kennedy earlier this year urging him to conduct more research on chlorine dioxide. 'This quiet removal won't immediately change everything, but it opens a door. If mainstream media reports on this shift, I believe it will unlock a new wave of serious [chlorine dioxide] research.' For decades, pseudoscience grifters have peddled chlorine dioxide solutions—sold under a variety of names, such as Miracle Mineral Solution—and despite warnings and prosecutions, have continued to claim the toxic substance is a 'cure' for everything from HIV to Covid-19 to autism. There is no credible evidence to back up any of these claims, which critics have long labeled as nothing more than a grift. The treatments typically involve drinking liquid chlorine dioxide on a regular basis, using solutions with concentrations of chlorine dioxide of around 3,000 parts per million (ppm), which is diluted further in water. Liu's treatment, however, involves a much higher concentration of chlorine dioxide—injections of several milliliters of 20,000ppm—and, rather than drinking it, patients have it injected directly into their tumors. Liu claims he has injected himself with the solution over 50 times and suffered no side effects. 'This personal data point encouraged me to continue research,' he says.
